K. S. Sridevi Sangeetha

Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia?

We read with great interest the study by Albliwi et al. 1 evaluating cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia (AML) and their clinical significance. The authors are to be congratulated for assembling a large cohort and providing valuable insights into the heterogeneous biology of these...